EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Immune Age, Cardiovascular Disease, and Anti-Viral Immunity

Kevin-Phu C Le iD, Fahad Shuja iD, Jorg J Goronzy, Cornelia M Weyand iD

Cells · 2025

DOI: 10.3390/cells14221793 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2025. Verfasst von Kevin-Phu C Le und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Aging, Virus Diseases. Die Arbeit nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIAMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular morbidity and mortality rise precipitously during the 6th–9th decades of life, identifying aging as a critical risk factor. Simultaneously, older individuals are susceptible to severe viral infection, raising the question whether shared mechanisms exist that predispose to both cardiovascular disease (CVD) and failing anti-viral immunity. The aging process causes steady decline in immune fitness (immune aging), which undermines the ability to generate protective anti-viral immune responses. Paradoxically, the aging immune system supports unopposed inflammatory pathways (inflammaging), which exacerbates tissue inflammation in CVD, specifically atherosclerosis. Here, we review the current evidence of how innate and adaptive immune aging promotes tissue-destructive inflammation in atherosclerosis while failing to fight viral infections. Further, we consider how these two disease processes mutually influence each other. We propose that mounting an effective anti-viral response induces off-target bystander activation and exhausts immune cells, ultimately exacerbating CVD. Additionally, we explore how atherosclerotic CVD impacts innate immunity through epigenetic modification of hematopoietic precursors and metabolically conditioning immune cells, leading to a dysfunctional immune system that accelerates plaque inflammation while simultaneously impairing host defense.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesAgingVirus DiseasesHumansAnimalsImmunity, InnateAdaptive ImmunityInflammationAtherosclerosis

Stichwörter der Autor:innen

B cell agingDNA methylationT cell agingatherosclerosiscardiovascular diseasehematopoietic stem cellimmune checkpointmacrophage agingviral infection

Autor:innen und Institutionen

  • Department of Medicine, Mayo Clinic, Rochester, MN 55905, USA.
  • Department of Immunology, Mayo Clinic, Rochester, MN 55905, USA.
  • Department of Cardiology, Mayo Clinic, Rochester, MN 55905, USA.
  • Division of Vascular and Endovascular Surgery, Department of Surgery, Mayo Clinic, Rochester, MN 55905, USA.
  • Department of Medicine, School of Medicine, Stanford University, Stanford, CA 94305, USA.

ORCID-Profile: Kevin-Phu C Le, Fahad Shuja, Cornelia M Weyand

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NIAMS NIH HHS
  • NIGMS NIH HHS
  • NIA NIH HHS

Zitieren

APA

Le, K. C., Shuja, F., Goronzy, J. J., & Weyand, C. M. (2025). Immune Age, Cardiovascular Disease, and Anti-Viral Immunity. Cells. https://doi.org/10.3390/cells14221793

Vancouver

Le KC, Shuja F, Goronzy JJ, Weyand CM. Immune Age, Cardiovascular Disease, and Anti-Viral Immunity. Cells. 2025. doi:10.3390/cells14221793

BibTeX
@article{Le2025,
  author = {Le, Kevin-Phu C and Shuja, Fahad and Goronzy, Jorg J and Weyand, Cornelia M},
  title = {Immune Age, Cardiovascular Disease, and Anti-Viral Immunity},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14221793}
}
Kostenlos starten →